Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

September 22, 2010

Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc. et al

Track this case

Case Number:

1:10-cv-00805

Court:

Delaware

Nature of Suit:

Patent

Judge:

Christopher J. Burke

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 12, 2013

    Judge Invalidates Bristol-Myers Patent For Hepatitis B Drug

    A Delaware federal judge on Monday struck down a Bristol-Myers Squibb Co. patent on the hepatitis B drug Baraclude as obvious, a ruling in favor of generic drugmaker Teva Pharmaceutical Industries Ltd., which had challenged the patent's validity.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login